These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10074120)

  • 1. Intranasal delivery of recombinant parvovirus-like particles elicits cytotoxic T-cell and neutralizing antibody responses.
    Sedlik C; Dridi A; Deriaud E; Saron MF; Rueda P; Sarraseca J; Casal JI; Leclerc C
    J Virol; 1999 Apr; 73(4):2739-44. PubMed ID: 10074120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity.
    Sedlik C; Dadaglio G; Saron MF; Deriaud E; Rojas M; Casal SI; Leclerc C
    J Virol; 2000 Jul; 74(13):5769-75. PubMed ID: 10846055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of parvovirus-like particles for vaccination and induction of multiple immune responses.
    Casal JI
    Biotechnol Appl Biochem; 1999 Apr; 29(2):141-50. PubMed ID: 10075910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells.
    Sedlik C; Saron M; Sarraseca J; Casal I; Leclerc C
    Proc Natl Acad Sci U S A; 1997 Jul; 94(14):7503-8. PubMed ID: 9207121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal immunisation with papillomavirus virus-like particles elicits systemic and mucosal immunity in mice.
    Liu XS; Abdul-Jabbar I; Qi YM; Frazer IH; Zhou J
    Virology; 1998 Dec; 252(1):39-45. PubMed ID: 9875315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design.
    Bessa J; Schmitz N; Hinton HJ; Schwarz K; Jegerlehner A; Bachmann MF
    Eur J Immunol; 2008 Jan; 38(1):114-26. PubMed ID: 18081037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recombinant virus-like particle system derived from parvovirus as an efficient antigen carrier to elicit a polarized Th1 immune response without adjuvant.
    Lo-Man R; Rueda P; Sedlik C; Deriaud E; Casal I; Leclerc C
    Eur J Immunol; 1998 Apr; 28(4):1401-7. PubMed ID: 9565380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions.
    Balmelli C; Roden R; Potts A; Schiller J; De Grandi P; Nardelli-Haefliger D
    J Virol; 1998 Oct; 72(10):8220-9. PubMed ID: 9733865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of systemic and mucosal cross-clade neutralizing antibodies in BALB/c mice immunized with human immunodeficiency virus type 1 clade A virus-like particles administered by different routes of inoculation.
    Buonaguro L; Visciano ML; Tornesello ML; Tagliamonte M; Biryahwaho B; Buonaguro FM
    J Virol; 2005 Jun; 79(11):7059-67. PubMed ID: 15890945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4-independent protective cytotoxic T cells induced in early life by a non-replicative delivery system based on virus-like particles.
    Martinez X; Regner M; Kovarik J; Zarei S; Hauser C; Lambert PH; Leclerc C; Siegrist CA
    Virology; 2003 Jan; 305(2):428-35. PubMed ID: 12573588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of immune responses induced by porcine parvovirus virus-like particles and inactivated vaccine.
    Tian W; Qiu Z; Cui Y; Zhang J; Ma X; Cui S; Zheng S
    Pak J Pharm Sci; 2019 Jan; 32(1(Special)):377-382. PubMed ID: 30852473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Route of administration of chimeric BPV1 VLP determines the character of the induced immune responses.
    Liu XS; Liu WJ; Zhao KN; Liu YH; Leggatt G; Frazer IH
    Immunol Cell Biol; 2002 Feb; 80(1):21-9. PubMed ID: 11869359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of mucosal immune responses by chimeric influenza HA/SHIV virus-like particles.
    Guo L; Lu X; Kang SM; Chen C; Compans RW; Yao Q
    Virology; 2003 Sep; 313(2):502-13. PubMed ID: 12954217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Co-expression of CSFV T cell epitope E290 peptide and PPV VP2 protein in Lactobacillus casei and determination of specific antibodies in immunized mice].
    Xu YG; Cui LC; Ge JW; Zhao LL; Li YJ
    Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):667-72. PubMed ID: 17944369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction, expression, and immunogenicity of chimeric HIV-1 virus-like particles.
    Wagner R; Deml L; Schirmbeck R; Niedrig M; Reimann J; Wolf H
    Virology; 1996 Jun; 220(1):128-40. PubMed ID: 8659105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-priming of T cell responses by synthetic microspheres carrying a CD8+ T cell epitope requires an adjuvant signal.
    Boisgérault F; Rueda P; Sun CM; Hervas-Stubbs S; Rojas M; Leclerc C
    J Immunol; 2005 Mar; 174(6):3432-9. PubMed ID: 15749877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Previous Respiratory Syncytial Virus Infection on Murine Immune Responses to F and G Protein-Containing Virus-Like Particles.
    McGinnes Cullen L; Schmidt MR; Morrison TG
    J Virol; 2019 May; 93(9):. PubMed ID: 30760576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimeric recombinant hepatitis E virus-like particles as an oral vaccine vehicle presenting foreign epitopes.
    Niikura M; Takamura S; Kim G; Kawai S; Saijo M; Morikawa S; Kurane I; Li TC; Takeda N; Yasutomi Y
    Virology; 2002 Feb; 293(2):273-80. PubMed ID: 11886247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering parvovirus-like particles for the induction of B-cell, CD4(+) and CTL responses.
    Rueda P; Martínez-Torrecuadrada JL; Sarraseca J; Sedlik C; del Barrio M; Hurtado A; Leclerc C; Casal JI
    Vaccine; 1999 Sep; 18(3-4):325-32. PubMed ID: 10506659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of recombinant Lactobacillus casei efficiently surface displayed and secreted porcine parvovirus VP2 protein and comparison of the immune responses induced by oral immunization.
    Yigang XU; Yijing LI
    Immunology; 2008 May; 124(1):68-75. PubMed ID: 18034821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.